Comparing the Effectiveness of Surgical versus Medical Approaches in Managing Patients with Indeterminate Spinal Instability Neoplastic Scores
Article Sidebar
Main Article Content
Abstract
Background. Treating indeterminate cases of spinal metastases (those with spinal instability neoplastic score [SINS] of 7–12) remains a clinical dilemma, as there are currently no well-defined recommendations for this category. This study aimed to identify the most appropriate approach for patients with indeterminate SINS by reviewing and analyzing published evidence.
Objective. To determine the effectiveness of surgical and medical approaches in managing spinal metastasis with indeterminate SINS.
Methodology. A comparative effectiveness study was conducted using systematic review and meta-analysis. A systematic search was performed in the following databases: PubMed, Embase, Cochrane Library, and Google Scholar. Studies were selected based on inclusion and exclusion criteria comparing surgical and medical approaches for indeterminate SINS. The outcomes analyzed were patients’ functional status, complications, and conversion to surgery/revision surgery. Quantitative data were analyzed using Review Manager version 5.3 software, and results were reported using a forest plot.
Results. Eight studies were included in the qualitative review, and six were included for quantitative synthesis, involving 1,312 patients. In patients with spinal metastasis with indeterminate SINS, surgery resulted in less functional decline than medical management, with a pooled odds ratio (OR) of 0.50 (95% CI: 0.31, 0.81). However, significantly more complications were associated with surgery (OR of 2.6; 95% CI: 1.66, 4.08). The authors reported a pooled result of 21.19% conversion to surgery among those initially managed with a medical approach. In the initial surgery group, there was a significant reduction in conversion to surgery or revision surgery, with an OR of 0.19 (95% CI: 0.10, 0.34).
Conclusion. This study addresses the dilemma of treating spinal metastasis with indeterminate instability, advocating for surgery as the primary intervention due to its potential to improve functional outcomes and provide a satisfactory quality of life, which may, in turn, influence overall survival. This topic can be explored further including identifying a specific SINS threshold that could serve as a criterion for recommending surgery.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Hussain I, Barzilai O, Reiner AS, et al. Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery. Spine J. 2018;18(2):26–7. https://pubmed.ncbi.nlm.nih.gov/28713049 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020735 https://doi.org/10.1016/j.spinee.2017.07.008 DOI: https://doi.org/10.1016/j.spinee.2017.07.008
Laufer I, Rubin DG, Lis E, et al. The NOMS Framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–51. https://pubmed.ncbi.nlm.nih.gov/23709750 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063402 https://doi.org/10.1634/theoncologist.2012-0293 DOI: https://doi.org/10.1634/theoncologist.2012-0293
Hong SH, Chang BS, Kim H, Kang DH, Chang SY. An updated review on the treatment strategy for spinal metastasis from the spine surgeon’s perspective. Asian Spine J. 2022;16(5):799–811. https://pubmed.ncbi.nlm.nih.gov/36266249 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633246 https://doi.org/10.31616/asj.2022.0367 DOI: https://doi.org/10.31616/asj.2022.0367
Quan GMY, Vital JM, Aurouer N, Obeid I, Palussière J, Diallo A, Pointillart V. Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients. Eur Spine J. 2011;20(11):1970–8. https://pubmed.ncbi.nlm.nih.gov/21706361 https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3207332 https://doi.org/10.1007/s00586-011-1867-6 DOI: https://doi.org/10.1007/s00586-011-1867-6
Chong S, Shin SH, Yoo H, et al. Single-stage posterior decompression and stabilization for metastasis of the thoracic spine: prognostic factors for functional outcome and patients’ survival. Spine J. 2012;12(12):1083–92. https://pubmed.ncbi.nlm.nih.gov/23168136 https://doi.org/10.1016/j.spinee.2012.10.015
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186–91. https://pubmed.ncbi.nlm.nih.gov/16205345 https://doi.org/10.1097/01.brs.0000180401.06919.a5 DOI: https://doi.org/10.1097/01.brs.0000180401.06919.a5
Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001;26(3):298–306. https://pubmed.ncbi.nlm.nih.gov/11224867 https://doi.org/10.1097/00007632-200102010-00016 DOI: https://doi.org/10.1097/00007632-200102010-00016
Katagiri H, Takahashi M, Wakai K, et al. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joitn Surg Br. 2005;87(5):698-703. https://pubmed.ncbi.nlm.nih.gov/15855375 https://doi.org/10.1302/0301-620X.87B5.15185 DOI: https://doi.org/10.1302/0301-620X.87B5.15185
Paton GR, Frangou E, Fourney DR. Contemporary treatment strategy for spinal metastasis: the “LMNOP” system. Can J Neurol Sci. 2011;38(3):396–403. https://pubmed.ncbi.nlm.nih.gov/ 21515496 https://doi.org/10.1017/s031716710001177x DOI: https://doi.org/10.1017/S031716710001177X
Ivanishvili Z, Fourney DR. Incorporating the spine instability neoplastic score into a treatment strategy for spinal metastasis: LMNOP. Global Spine J. 2014;4(2):129–35. https://pubmed.ncbi.nlm.nih.gov/25054100 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078113 https://doi.org/10.1055/s-0034-1375560 DOI: https://doi.org/10.1055/s-0034-1375560
Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease. Spine (Phila Pa 1976). 2010;35(22):E1221–9. https://pubmed.ncbi.nlm.nih.gov/20562730 https://doi.org/10.1097/BRS.0b013e3181e16ae2 DOI: https://doi.org/10.1097/BRS.0b013e3181e16ae2
Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia. 1969;7(3):179–92. https://pubmed.ncbi.nlm.nih.gov/ 5360915 https://doi.org/10.1038/sc.1969.30 DOI: https://doi.org/10.1038/sc.1969.30
Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. New York: Columbia University Press; 1949.
Zadnik PL, Goodwin CR, Karami KJ, et al. Outcomes following surgical intervention for impending and gross instability caused by multiple myeloma in the spinal column. J Neurosurg Spine. 2015;22(3):301–9. https://pubmed.ncbi.nlm.nih.gov/25575166 https://doi.org/10.3171/2014.9.SPINE14554 DOI: https://doi.org/10.3171/2014.9.SPINE14554
Donnellan CJ, Roser S, Maharaj MM, et al. Outcomes for vertebrectomy for malignancy and correlation to the Spine Instability Neoplastic Score (SINS): a 10-year single-center perspective. World Neurosurg. 2020;138:e151–9. https://pubmed.ncbi.nlm.nih.gov/32081818 https://doi.org/10.1016/j.wneu.2020.02.048 DOI: https://doi.org/10.1016/j.wneu.2020.02.048
Dial BL, Catanzano AA, Esposito V, et al. Treatment outcomes in spinal metastatic disease with indeterminate stability. Global Spine J. 2020;12(3):373–80. https://pubmed.ncbi.nlm.nih.gov/32975442 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121158 https://doi.org/10.1177/2192568220956605 DOI: https://doi.org/10.1177/2192568220956605
Vargas E, Shabani S, Mummaneni PV, et al. Does surgery for metastatic spinal tumors improve functional outcomes in patients without spinal cord compression but with potentially unstable spines (SINS 7–12)? Journal of Neurosurgery Spine. 2023:39(2):287-94. https://pubmed.ncbi.nlm.nih.gov/37148234 https://doi.org/10.3171/2023.3.SPINE221120 DOI: https://doi.org/10.3171/2023.3.SPINE221120
Lenschow M, Lenz M, Von Spreckelsen N, et al. Impact of spinal instrumentation on neurological outcome in patients with intermediate Spinal Instability Neoplastic Score (SINS). Cancers (Basel). 2022;14(9):2193. https://pubmed.ncbi.nlm.nih.gov/35565322 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101027 https://doi.org/10.3390/cancers14092193 DOI: https://doi.org/10.3390/cancers14092193
Versteeg AL, Sahgal A, Rhines LD, et al. Health related quality of life outcomes following surgery and/or radiation for patients with potentially unstable spinal metastases. Spine J. 2021;21(3):492-–9. https://pubmed.ncbi.nlm.nih.gov/33098985 https://doi.org/10.1016/j.spinee.2020.10.017 DOI: https://doi.org/10.1016/j.spinee.2020.10.017
Vargas E, Lockney DT, Mummaneni PV, et al. An analysis of tumor-related potential spinal column instability (Spine Instability Neoplastic Scores 7–12) eventually requiring surgery with a 1-year follow-up. Neurosurg Focus. 2021;50(5):E6. https://pubmed.ncbi.nlm.nih.gov/33932936 https://doi.org/10.3171/2021.2.FOCUS201098 DOI: https://doi.org/10.3171/2021.2.FOCUS201098
Kim YH, Kim J, Chang SY, et al. Treatment strategy for impending instability in spinal metastases. Clin Orthop Surg. 2020;12(3):337. https://pubmed.ncbi.nlm.nih.gov/32904056 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449857 https://doi.org/10.4055/cios20014 DOI: https://doi.org/10.4055/cios20014
Dea N, Versteeg AL, Sahgal A, et al. Metastatic spine disease: Should patients with short life expectancy be denied surgical care? an international Retrospective cohort study. Neurosurgery. 2019;87(2):303–11. https://pubmed.ncbi.nlm.nih.gov/31690935 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360875 https://doi.org/10.1093/neuros/nyz472 DOI: https://doi.org/10.1093/neuros/nyz472
Park SJ, Ma CH, Lee CS, et al. Survival and Functional Outcomes after Surgical Treatment for Spinal Metastasis in Patients with a Short Life Expectancy. Journal of Clinical Medicine. 2022;12(1):46. https://pubmed.ncbi.nlm.nih.gov/12518372 https://doi.org/10.1002/cncr.11039 DOI: https://doi.org/10.3390/jcm12010046
Hirabayashi H, Ebara S, Kinoshita T, et al. Clinical outcome and survival after palliative surgery for spinal metastases. Cancer. 2003;97(2):476–84. https://pubmed.ncbi.nlm.nih.gov/12518372 https://doi.org/10.1002/cncr.11039 DOI: https://doi.org/10.1002/cncr.11039
Younsi A, Riemann L, Scherer M, Unterberg A, Zweckberger K. Impact of decompressive laminectomy on the functional outcome of patients with metastatic spinal cord compression and neurological impairment. Clin Exp Metastasis. 2020;37(2):377–90. https://pubmed.ncbi.nlm.nih.gov/31960230 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138774 https://doi.org/10.1007/s10585-019-10016-z DOI: https://doi.org/10.1007/s10585-019-10016-z
Chong S, Shin SH, Yoo H, et al. Single-stage posterior decompression and stabilization for metastasis of the thoracic spine: prognostic factors for functional outcome and patients’ survival. Spine J. 2012;12(12):1083–92. https://pubmed.ncbi.nlm.nih.gov/ 23168136 https://doi.org/10.1016/j.spinee.2012.10.015 DOI: https://doi.org/10.1016/j.spinee.2012.10.015
Choi D, Fox Z, Albert T, et al. Prediction of quality of life and survival after surgery for symptomatic spinal metastases. Neurosurgery. 2015;77(5):698–708. https://pubmed.ncbi.nlm.nih.gov/26204361 https://doi.org/10.1227/NEU.0000000000000907 DOI: https://doi.org/10.1227/NEU.0000000000000907
Candido PBM, Peria FM, Toledo VN, et al. Complications of Surgical Treatment of Spinal Metastases. Coluna/Columna. 2021;20(4):300-4. https://doi.org/10.1590/S1808-185120212004255227 DOI: https://doi.org/10.1590/s1808-185120212004255227
Igoumenou VG, Mavrogenis AF, Angelini A, et al. Complications of spine surgery for metastasis. Eur J Orthop Surg Traumatol. 2019;30(1):37–56. https://pubmed.ncbi.nlm.nih.gov/31473821 https://doi.org/10.1007/s00590-019-02541-0 DOI: https://doi.org/10.1007/s00590-019-02541-0
Kim JM, Losina E, Bono CM, et al. Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature. Spine. 2011;37(1):78–84. https://pubmed.ncbi.nlm.nih.gov/21629164 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876411 Dhttps://doi.org/10.1097/BRS.0b013e318223b9b6 DOI: https://doi.org/10.1097/BRS.0b013e318223b9b6
Tarawneh AM, Pasku D, Quraishi NA. Surgical complications and re-operation rates in spinal metastases surgery: a systematic review. Eur Spine J. 2020;30(10):2791-9. https://pubmed.ncbi.nlm.nih.gov/33184702 https://doi.org/10.1007/s00586-020-06647-6 DOI: https://doi.org/10.1007/s00586-020-06647-6
Lau D, Leach MR, Than KD, Ziewacz J, La Marca F, Park P. Independent predictors of complication following surgery for spinal metastasis. Eur Spine J. 2013;22(6):1402–7. https://pubmed.ncbi.nlm.nih.gov/23392558 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676566 https://doi.org/10.1007/s00586-013-2706-8 DOI: https://doi.org/10.1007/s00586-013-2706-8
Yang Z, Yang Y, Zhang Y, et al. Minimal access versus open spinal surgery in treating painful spine metastasis: a systematic review. World J Surg Oncol. 2015;13(1):68. https://pubmed.ncbi.nlm.nih.gov/25880538 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342220 https://doi.org/10.1186/s12957-015-0468-y DOI: https://doi.org/10.1186/s12957-015-0468-y
Hamad A, Vachtsevanos L, Cattell A, Ockendon M, Balain B. Minimally invasive spinal surgery for the management of symptomatic spinal metastasis. Br J Neurosurg. 2017;31(5):526–30. https://pubmed.ncbi.nlm.nih.gov/28264589 https://doi.org/10.1080/02688697.2017.1297374 DOI: https://doi.org/10.1080/02688697.2017.1297374
Colangeli S, Capanna R, Bandiera S, et al. Is minimally-invasive spinal surgery a reliable treatment option in symptomatic spinal metastasis? Eur Rev Med Pharmacol Sci. 2020;24(12):6526–32. https://pubmed.ncbi.nlm.nih.gov/32633339 https://doi.org/10.26355/eurrev_202006_21636
Vargas E, Susko MS, Mummaneni PV, Braunstein SE, Chou D. Vertebral body fracture rates after stereotactic body radiation therapy compared with external-beam radiation therapy for metastatic spine tumors. J Neurosurg Spine. 2020;33(6):870–6. https://pubmed.ncbi.nlm.nih.gov/32796141 https://doi.org/10.3171/2020.5.SPINE191383 DOI: https://doi.org/10.3171/2020.5.SPINE191383
Guninski RS, Cuccia F, Alongi F, et al. Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline. Radiother Oncol. 2024;190:109969. https://pubmed.ncbi.nlm.nih.gov/37922993 https://doi.org/10.1016/j.radonc.2023.109969 DOI: https://doi.org/10.1016/j.radonc.2023.109969
Sprave T, Verma V, Förster R, et al. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiotherapy and Oncology. 2018;128(2):274–82. https://pubmed.ncbi.nlm.nih.gov/35917886 https://doi.org/10.1016/j.critrevonc.2022.103775 DOI: https://doi.org/10.1016/j.radonc.2018.04.030
Lee CC, Soon YY, Cheo T, Vellayappan B, Tey J. Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hemat. 2022;178:103775. https://pubmed.ncbi.nlm.nih.gov/35917886 https://doi.org/10.1016/j.critrevonc.2022.103775 DOI: https://doi.org/10.1016/j.critrevonc.2022.103775
Pennington Z, Ahmed AK, Westbroek EM, et al. SINS Score and stability: evaluating the need for stabilization within the uncertain category. World Neurosurg. 2019;128:e1034–47. https://pubmed.ncbi.nlm.nih.gov/31103761 https://doi.org/10.1016/j.wneu.2019.05.067 DOI: https://doi.org/10.1016/j.wneu.2019.05.067